Comments
Skepticism grows around Medco/Express Scripts deal
07.02.2012. | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as U.S. antitrust regulators weigh whether they have enough evidence to stop the megamerger....
